To better understand the molecular signatures after the combined inhibition of UBE2C and PLK1 in Lv-NCI-H460 and Lv-MCF7 tumor cells, we performed an RNA-seq analysis and analyzed the DEGs. Here, UBE2C is linked to neoplasm.